Kessler, L. et al. 2015. A retrospective safety and efficacy analysis of the first patients treated with eribulin for metastatic breast cancer in Stockholm, Sweden. Acta Oncologica. 54, 4 (Apr. 2015), 527–534. DOI:https://doi.org/10.3109/0284186X.2014.973063.